Immune Dysregulation and Infectious Complications in MPN Patients Treated With JAK Inhibitors
BCR-ABL1-negative myeloproliferative neoplasms are burdened by a reduced life expectancy mostly due to an increased risk of thrombo-hemorrhagic events, fibrotic progression/leukemic evolution, and infectious complications. In these clonal myeloid malignancies, JAK2V617F is the main driver mutation,...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Frontiers Media S.A.
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/f0387f2811bc4960a7bb65e2a6fc62db |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|